Advertisement
Screener

VITASPRING BIOMEDICAL CO., LTD. (VSBC) Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)

2.8 / 5 stars · 68/120 Roast Me

VITASPRING BIOMEDICAL CO., LTD. Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)

VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) of 7.14 million shares for the 12-month period ending 2022-01-31, per its 10-K filed 2022-05-03.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease · last filed 2022-05-03

  • VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2022-01-31 was 0.00 shares.
  • VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2021-10-31 was 0.00 shares.
  • VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, other share increase (decrease) for fiscal 2022 was 7.14M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 12 month
2022-01-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-03
0.00 shares
derived: sum of 2 quarters · filed 2022-05-03
7.14M shares
10-K · filed 2022-05-03
2021-10-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-23
7.14M shares
10-Q · filed 2021-12-23
2021-07-317.14M shares
10-Q · filed 2021-09-15